NIce Recommendations : Blinatumomab with chemotherapy can be used as an option to treat Philadelphia-chromosome-negative CD19-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in adults

Nice recommended the use of Blinatumomab with chemotherapy  as an option to treat Philadelphia-chromosome-negative CD19-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in adults, if:
• the leukaemia is minimal residual disease-negative
• it is used at the start of consolidation treatment
• the company provides it according to the commercial arrangement.

Final draft guidance at this link